Goldman Sachs’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-115,801
| Closed | -$37K | – | 4419 |
|
|
2018
Q1 | $37K | Buy |
+115,801
| New | +$37K | ﹤0.01% | 4110 |
|
|
2017
Q3 | – | Sell |
-42,692
| Closed | -$69K | – | 4521 |
|
|
2017
Q2 | $69K | Sell |
42,692
-2,306
| -5% | -$3.73K | ﹤0.01% | 4211 |
|
|
2017
Q1 | $153K | Buy |
44,998
+41,950
| +1,376% | +$143K | ﹤0.01% | 4017 |
|
|
2016
Q4 | $16K | Sell |
3,048
-344
| -10% | -$1.81K | ﹤0.01% | 4382 |
|
|
2016
Q3 | $85K | Buy |
3,392
+944
| +39% | +$23.7K | ﹤0.01% | 4223 |
|
|
2016
Q2 | $61K | Buy |
2,448
+389
| +19% | +$9.69K | ﹤0.01% | 4237 |
|
|
2016
Q1 | $60K | Sell |
2,059
-13,463
| -87% | -$392K | ﹤0.01% | 4172 |
|
|
2015
Q4 | $576K | Buy |
15,522
+10,818
| +230% | +$401K | ﹤0.01% | 3175 |
|
|
2015
Q3 | $229K | Sell |
4,704
-3,467
| -42% | -$169K | ﹤0.01% | 3786 |
|
|
2015
Q2 | $563K | Buy |
8,171
+5,839
| +250% | +$402K | ﹤0.01% | 3268 |
|
|
2015
Q1 | $83K | Sell |
2,332
-2,414
| -51% | -$85.9K | ﹤0.01% | 4188 |
|
|
2014
Q4 | $60K | Buy |
+4,746
| New | +$60K | ﹤0.01% | 4349 |
|